Physician profile
Xiaoping Chen
NPI 1962055764
$2,165.23
in general payments reported to CMS, 2019-2025
10 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $242 · 2023: $738 · 2024: $739 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,636.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,026.69 | 2023-2025 | |
| Gilead Sciences, INC. | $677.42 | 2021-2025 | |
| Amarin Pharma, INC. | $150.94 | 2021-2023 | |
| Glaxosmithkline, LLC. | $148.26 | 2022-2023 | |
| Esperion Therapeutics, INC. | $43.24 | 2021 | |
| Neurelis, INC. | $32.50 | 2023 | Valtoco |
| Novo Nordisk INC | $25.00 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $22.95 | 2022 | |
| Horizon Therapeutics Plc | $20.03 | 2022 | |
| Acadia Pharmaceuticals INC | $18.20 | 2025 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaoping Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.